ANTI-IDIOTYPIC ANTIBODY WHICH NEUTRALIZES THE INHIBITORY ACTIVITY OF AN INHIBITORY ANTIBODY DIRECTED AGAINST THE C1 DOMAIN OF FACTOR VIII

摘要

The present invention relates to an anti-idiotypic monoclonal antibody directed against a factor VIII-inhibiting antibody which binds to the C1 domain of factor VIII, and also to a cell line which produces this anti-idiotypic monoclonal antibody, to the use of this anti-idiotypic monoclonal antibody as a medicament, and more particularly to its use for the manufacture of a medicament for use in the treatment of haemophilia A.